This Tiny Tech Stock Could Be the Next Big Platform Play
One under-the-radar company is embedding intelligence into everyday glass-already powering Ferraris, aircraft, and city buses with adaptive surfaces and vision systems. It's not just a product. It's a platform.
About GSK Plc ADR
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.
General
Name | GSK Plc ADR |
Ticker | GSK |
Exchange | NYSE |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Currency | USD |
Country | USA |
Fiscal Year End | December |
Full Time Employees | 68,629 |
Highlights
Analyst Target | 44.57 |
Market Cap | 77,314,500,000 |
PE Ratio | 19.86 |
PEG Ratio | 0.38 |
EBITDA | 8,654,000,128 |
Share Stats
Shares Outstanding | 2,042,500,000 |
Shares Float | 2,020,950,000 |
Shares Short | 18,500,000 |
Insider Holdings | 6% |
Institution Holdings | 18.20% |
Highlights
Analyst Target | 44.57 |
Market Cap | 77,314,500,000 |
PE Ratio | 19.86 |
PEG Ratio | 0.38 |
EBITDA | 8,654,000,128 |
Valuation
Trailing PE | 18.36 |
Forward PE | 8.63 |
Price/Sales (Trailing 12 Mt.) | 2.46 |
Price/Book (Most Recent Quarter) | 4.04 |
Dividend
GSK Plc ADR pays out a dividend of $1.77 per share, with a dividend yield of 4.63%.
GSK's last dividend payment was made to shareholders on July 10, 2025.
They pay out 94.89% of their earnings out as a dividend.
Recent Dividends
Jul 10, 2025 | $0.43 |
Apr 10, 2025 | $0.40 |
Jan 9, 2025 | $0.39 |
Oct 10, 2024 | $0.39 |
Jul 11, 2024 | $0.38 |
Apr 11, 2024 | $0.41 |
Jan 11, 2024 | $0.34 |
Oct 12, 2023 | $0.36 |
Meta CEO Mark Zuckerberg expected to testify in $8 billion Facebook privacy lawsuit
A $8 billion-dollar class action investors’ lawsuit against Meta CEO Mark Zuckerberg and company leaders — current and former — begins Wednesday, with claims stemming from the privacy scandal involving the political consulting firm.
The online gunseller with Donald Trump Jr. on its board makes its market debut. Shares plunge
WASHINGTON (AP) — Online firearms seller GrabAGun Digital Holdings, with the stock ticker “PEW,” made its market debut on Wednesday after board member and son of the U.S. president, Donald Trump Jr., rang the opening bell at the New York Stock Exchange.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Do as I say, not as I do: On my failings as an investor
If a knowledgeable observer trained his or her sights on my choices, what are the trouble spots they would identify? Here are some of the biggies.
S&P 500 Defies Odds With Rare Rally — But 'Toppy' Sentiment Creeps In
The S&P 500 just posted a rare 26% rally in three months. History points to more upside, but investor sentiment looks stretched.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
France, UK and Germany would restore UN sanctions on Iran next month without progress on a deal
UNITED NATIONS (AP) — The United Kingdom, France and Germany have agreed to restore tough U.N. sanctions on Iran by the end of August if there has been no concrete , two European diplomats said Tuesday.
OpenAI Says Tokens Are Not Equity, No Partnership With Robinhood: Musk Says AI Company's Equity 'Is Fake'
OpenAI says the "OpenAI tokens" offered by Robinhood are not OpenAI equity and clarified that it has no partnership or involvement with Robinhood.
Elon's Greatest Invention... Hidden in South Memphis? - Ad
In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.
Rocket Lab (RKLB) Stock Hits New All-Time High As Citi Boosts Price Target
Rocket Lab shares hit a new all-time high in early Monday trading. The stock is being fueled by a price target increase from Citigroup.
Energy ETFs In Focus After Exxon Flags $1.5 Billion Profit Hit
Exxon's caution pressures energy ETFs like XLE and VDE, as oil prices dip and investors weigh OPEC+ moves and sector rotation risks.
Gold Just Hit Another Record. This Junior Could Be Next. - Ad
This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.
Cramer Praises Monster Beverage As 'Smoking Hot,' Warns Investors About This AI Stock
Cramer recommends buying Okta (OKTA) as it reported strong earnings, but not to trust Nebius Group (NBIS), while Sweetgreen (SG) and Monster Beverage (MNST) have mixed views. He also suggests buying McDonald's (MCD) while their partnership with Krispy Kreme (DNUT) will end in 2025.
Here's Why 'Altcoin Season' For XRP, ETH, SOL Has Not Happened Yet
Cryptocurrency analyst Benjamin Cowen has argued that an ‘altcoin season‘ has failed to materialize due to monetary policy, liquidity and stubborn Bitcoin (CRYPTO:
Copper's Spiking - And This Junior Has the Grades to Match - Ad
Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.
Home Depot's $5.5B Deal Expands Its Reach To Thousands Of Job Sites
Analyst maintains Buy rating on Home Depot with $450 price target, noting plans for subsidiary SRS Distribution to acquire GMS for $4.3B.
Elizabeth Warren Slams Trump's Plan To 'Gut' Sesame Street Funding — 'If He Gets Away With This, Next Time….'
Sen. Elizabeth Warren slammed a Republican-backed plan to slash funding for public broadcasting, warning it's part of Donald Trump's broader agenda to gut essential public services like education, housing, and climate programs.
Copper's Rally Is Back. This $31M Junior Is Sitting on a Potential Fortune - Ad
A high-grade copper-gold discovery in Quebec just delivered extremely high grade intercepts. Valuation? Just $31M. With copper breaking out, the timing here could be perfect. Get the symbol here.
Tesla sales fell 13% in the last three months as anti-Musk sentiment still has an effect
NEW YORK (AP) — Sales of Tesla electric cars fell 13% in the last three months as boycotts over Elon Musk's political views continue to keep buyers away, a significant development given expectations that anger with the company's billionaire CEO would have faded by now.
Boeing Rises 2.8% After Key Trading Signal
A significant trading signal occurred for Boeing stock, as it demonstrated a power inflow at $209.02, after which BA rose up to 2.8%.
Stunning Policy Unlocks Upfront Payouts - Ad
Thanks to Title 15 of the U.S. Code, everyday Americans can now collect $100-$1,000 upfront - without owning a single stock. Jeff Clark will tell you about a unique income strategy that's had a 100% win rate in 2025.
Hong Kong plans to regulate Uber and other online ride-hailing services
HONG KONG (AP) — The Hong Kong government on Tuesday unveiled proposals to provided by tech companies like Uber, requiring platforms, cars and drivers to be licensed before hitting the road.
Cathie Wood's Thursday Crypto Moves: Ark Unloads Nearly $25 Million In Coinbase, Block Stocks
On Thursday, Cathie Wood-led Ark Invest made notable trades, including the sale of shares in Coinbase Global Inc. (NASDAQ:COIN) and Block Inc. (NYSE:XYZ).
From Ferrari to Bombardier - This Tiny Company Is Everywhere - Ad
A $150M disruptor is transforming glass into real-time displays and vision systems. Already embedded in global OEMs and Tier 1s, it's scaling fast - yet still under Wall Street's radar.
Inside The Trump Family's $620 Million Crypto Empire
Since retaking the White House, Donald Trump's reported net worth has remained broadly stable, around $6.5 billion on Election Day to roughly $6.4 billion today.
Trump Threatens 10% 'Additional' Tariff On All BRICS-Aligned Nations, Says Tariff Letters Drop At Noon Monday
President Trump announced on Sunday that he will impose an additional 10% tariff on any country aligning with BRICS anti-American policies.
The Next Big Breakout Isn't a Chip. It's Glass. - Ad
Smartphones disrupted phones. EVs disrupted autos. Now smart surfaces are disrupting everything - and one overlooked company is at the center of it.
Lisa Murkowski Defends Alaska Carveouts As Elizabeth Warren, Bernie Sanders And Rand Paul Condemn Trump's 'Big Beautiful' Bill: 'Not Good Enough For The Rest Of Our Nation'
Senators across party lines are fiercely divided over Donald Trump's $3.3 trillion "Big Beautiful Bill," which narrowly passed the Senate and now heads to the House amid concerns over debt, tax cuts, and social program rollbacks.
Asia Markets Mixed, Europe Gains, Dollar Hit by Fed Concerns And Cooling Inflation - Global Markets Today While US Slept
US markets closed mixed on Wednesday, tech shares lifted Nasdaq while S&P 500 remained flat. Fed Chair Powell reiterated wait-and-see approach. Asian markets mostly up, European markets also positive with oil prices steady.
This Tiny Tech Stock Could Be the Next Big Platform Play - Ad
One under-the-radar company is embedding intelligence into everyday glass-already powering Ferraris, aircraft, and city buses with adaptive surfaces and vision systems. It's not just a product. It's a platform.
Crew abandons Liberian-flagged, Greek-owned ship attacked in the Red Sea, UK military says
DUBAI, United Arab Emirates (AP) — Crew members aboard a Liberian-flagged ship set ablaze by a series of attacks in the Red Sea abandoned the vessel Sunday night as it took on water, marking the first serious assault in the vital corridor for trade after a monthslong campaign by there.
Iran’s president orders country to suspend cooperation with UN nuclear watchdog IAEA
DUBAI, United Arab Emirates (AP) — Iran’s president on Wednesday ordered the country to suspend its cooperation with after American and Israeli airstrikes hit its most-important nuclear facilities, likely further limiting inspectors' ability to track Tehran's program that had been enriching uranium to near weapons-grade levels.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Donald Trump Drops Hint About Potential TikTok Buyer, But Keeps Details Close To His Chest
President Trump has indicated the presence of a potential buyer for the US operations of TikTok.
AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment
AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ivonescimab.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
On This Day 15 Years Ago, Elon Musk's Tesla Took A Risk On The Public Markets — Now It's Paid Off Nearly 300 Times Over
Tesla marks its 15th anniversary of its IPO with a staggering 300-fold surge in its stock value.
Scott Bessent On Replacing Powell As Fed Chair: 'I Will Do What The President Wants' — Plays Down Shadow Chair Speculations
U.S. Treasury Secretary Scott Bessent declined to rule out the possibility of replacing Jerome Powell as Federal Reserve Chair and has instead deferred to President Donald Trump's decision on the matter.
Elon's Greatest Invention... Hidden in South Memphis? - Ad
In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.
ProKidney Stock Shoots Up Over 8% After Hours After Staggering 515% Rally On Wednesday
ProKidney (NASDAQ: PROK) experienced a surge of 515% during Tuesday's trading session and gained additional 8.58% after-hours to $4.05 on positive Phase 2 trial results, with trading volume seeing a jump to 39.8 million shares from an average of 1.12 million.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.